Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Abatacept in rheumatoid arthritis: survival on drug, clinical outcomes, and their predictors—data from a large national quality register

Fig. 1

Survival on abatacept by previous bDMARD exposure. Drug continuation rates in patients treated with no previous bDMARD, 1 previous bDMARD, and ≥ 2 previous bDMARDs. Significant difference (p = 0.001, log-rank test) due to lower abatacept discontinuation in patients with no previous bDMARDs compared to those with 1 or ≥ 2 previous bDMARDs

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us